How To Accelerate Trial Enrollment: What Works And What Doesn't

By Mark Summers and Seth Nelson

Enrollment delays are the norm for clinical studies today, adding unnecessary costs and delays in delivering new medicines to patients who need them. As the problem continues to grow, sponsors can improve timelines and achieve ROI using enrollment acceleration strategies. But before you evaluate strategies, it’s important to understand what problems you need to solve. The common approaches to enrollment acceleration do not work because they do not adequately address the two root causes of slow enrollment. A new approach addresses both root causes and accelerates study timelines by an average of 33 percent.